American Dream's Nightmare Ends, But It Doubts NAD Standard For Claims
This article was originally published in The Rose Sheet
Dietary supplement multi-level marketer American Dream says it will comply with NAD's recommendations even though "it disagrees with the standard NAD applied to its claims for its dietary supplement."
You may also be interested in...
NAD refers UltraMax Health's supplement claim to the FTC after it fails to provide substantiation. CRN emphasizes claims alone are not the problem, but the firm's failure to provide substantiation.
FTC's "standard is the same. There's not any per se lower standard for substantiation just because you position your product as a supplement," says agency attorney Michelle Rusk. Supplement industry stakeholders, though, argue that FTC has no basis to require RCTs for structure/function claims.
NAD refers questions about PhytoZon claims to FDA and FTC after American Dream declines to submit evidence in a challenge by the Council for Responsible Nutrition. The multi-level marketer refers NAD attorneys to its website with links to around 500 studies, which look at ingredients and not the product.